학술논문
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
Document Type
Article
Author
Source
In Journal of Controlled Release 28 June 2018 280:113-123
Subject
Language
ISSN
0168-3659